BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 16141388)

  • 1. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.
    Buchanan J; Mazumder PK; Hu P; Chakrabarti G; Roberts MW; Yun UJ; Cooksey RC; Litwin SE; Abel ED
    Endocrinology; 2005 Dec; 146(12):5341-9. PubMed ID: 16141388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.
    Mazumder PK; O'Neill BT; Roberts MW; Buchanan J; Yun UJ; Cooksey RC; Boudina S; Abel ED
    Diabetes; 2004 Sep; 53(9):2366-74. PubMed ID: 15331547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.
    Belke DD; Larsen TS; Gibbs EM; Severson DL
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1104-13. PubMed ID: 11052966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid metabolism is enhanced in type 2 diabetic hearts.
    Carley AN; Severson DL
    Biochim Biophys Acta; 2005 May; 1734(2):112-26. PubMed ID: 15904868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E; Cooper M; Severson DL; Larsen TS
    Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes in mice with monogenic obesity: the db/db mouse and its use in the study of cardiac consequences.
    Belke DD; Severson DL
    Methods Mol Biol; 2012; 933():47-57. PubMed ID: 22893400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.
    Golfman LS; Wilson CR; Sharma S; Burgmaier M; Young ME; Guthrie PH; Van Arsdall M; Adrogue JV; Brown KK; Taegtmeyer H
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E328-36. PubMed ID: 15797988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
    Hafstad AD; Khalid AM; How OJ; Larsen TS; Aasum E
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1288-94. PubMed ID: 17213470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.
    Tabbi-Anneni I; Buchanan J; Cooksey RC; Abel ED
    Endocrinology; 2008 Aug; 149(8):4043-50. PubMed ID: 18450963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.
    Aasum E; Hafstad AD; Severson DL; Larsen TS
    Diabetes; 2003 Feb; 52(2):434-41. PubMed ID: 12540618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice.
    Dubuc PU
    Metabolism; 1976 Dec; 25(12):1567-74. PubMed ID: 994838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
    Carley AN; Semeniuk LM; Shimoni Y; Aasum E; Larsen TS; Berger JP; Severson DL
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart.
    Wang P; Chatham JC
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E725-36. PubMed ID: 14722022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity.
    Boudina S; Sena S; O'Neill BT; Tathireddy P; Young ME; Abel ED
    Circulation; 2005 Oct; 112(17):2686-95. PubMed ID: 16246967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator.
    Aasum E; Belke DD; Severson DL; Riemersma RA; Cooper M; Andreassen M; Larsen TS
    Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H949-57. PubMed ID: 12181123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central leptin signaling is required to normalize myocardial fatty acid oxidation rates in caloric-restricted ob/ob mice.
    Sloan C; Tuinei J; Nemetz K; Frandsen J; Soto J; Wride N; Sempokuya T; Alegria L; Bugger H; Abel ED
    Diabetes; 2011 May; 60(5):1424-34. PubMed ID: 21441440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
    Howarth AG; Wiehler WB; Pannirselvam M; Jiang Y; Berger JP; Severson D; Anderson TJ; Triggle CR
    J Pharmacol Exp Ther; 2006 Jan; 316(1):364-70. PubMed ID: 16249369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
    Garris DR; Garris BL
    Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.